Rhenman & Partners Asset Management AB Reduces Elevance Health Stake

Institutional investor sells over 22,000 shares of healthcare company

Published on Mar. 8, 2026

Got story updates? Submit your updates here. ›

Rhenman & Partners Asset Management AB, an institutional investor, has lowered its holdings in Elevance Health, Inc. (NYSE:ELV) by 49.6% during the third quarter, according to a recent SEC filing. The firm now owns 22,500 shares of the company's stock, down from 44,650 shares previously.

Why it matters

This move by Rhenman & Partners Asset Management AB reflects broader trends in the healthcare industry, as investors closely monitor factors like regulatory changes, mergers and acquisitions, and shifts in consumer demand. Elevance Health is one of the largest health benefits companies in the U.S., so changes to its shareholder base can provide insights into investor sentiment around the sector.

The details

According to the SEC filing, Rhenman & Partners Asset Management AB sold 22,150 shares of Elevance Health during the third quarter, reducing its total stake in the company to 22,500 shares. The firm's holdings in Elevance Health were valued at $7.27 million as of the most recent filing period.

  • Rhenman & Partners Asset Management AB lowered its Elevance Health holdings during the third quarter of 2026.

The players

Rhenman & Partners Asset Management AB

An institutional investor and asset management firm.

Elevance Health, Inc.

A large U.S.-based health benefits company that provides a broad range of health insurance products and related services.

Got photos? Submit your photos here. ›

The takeaway

This reduction in Elevance Health's institutional ownership could signal broader shifts in investor sentiment around the healthcare sector, as firms like Rhenman & Partners Asset Management AB adjust their portfolios in response to market conditions and industry trends.